Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Wall Street
Price Targets
Price Targets Summary
Fujian Aonong Biological Technology Group Incorporation Ltd
Price Targets
Revenue
Forecast
Revenue Estimate
Fujian Aonong Biological Technology Group Incorporation Ltd
For the last 7 years the compound annual growth rate for Fujian Aonong Biological Technology Group Incorporation Ltd's revenue is 27%. The projected CAGR for the next 3 years is 17%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Fujian Aonong Biological Technology Group Incorporation Ltd's stock price target?
Not Available
Fujian Aonong Biological Technology Group Incorporation Ltd doesn't have any price targets made by Wall Street professionals.
What is Fujian Aonong Biological Technology Group Incorporation Ltd's Revenue forecast?
Projected CAGR
17%
For the last 7 years the compound annual growth rate for Fujian Aonong Biological Technology Group Incorporation Ltd's revenue is 27%. The projected CAGR for the next 3 years is 17%.